News

Examining mechanisms of protein complex at a basic cell biological level

Patrick Sargent
By Patrick Sargent
Feb. 1, 2025

A new study highlighting the importance of a large protein complex called the exocyst in cell growth, division and communication reveals new functions and mechanisms that are essential to how molecules move across a membrane through vesicles in a cell.

Mary Munson
Faith Ninivaggi
Mary Munson

Understanding how these mechanisms work in normal cells at the basic biological level will inform future research into how those functions are disrupted in developmental and neurological disorders.

“It’s the first time a role for membrane fusion has been described for this complex and it’s a breakthrough in how we think about the way the exocyst complex works,” said Mary Munson, professor and vice chair for diversity in the Department of Biochemistry & Molecular Biotechnology, associate vice provost for equity in science in the Office of Health Equity and a co-corresponding author on the study published in Nature Structural & Molecular Biology. The research was done in collaboration with Tae-Young Yoon, professor of biological sciences at the School of Biological Sciences and Institute for Molecular Biology and Genetics at Seoul National University in Seoul, South Korea.

“Until our collaborative study, exocyst was understood to recognize and possibly tether secretory vesicles to the cell membrane, prior to exocytosis. In this study, we reveal biophysical studies that indicate exocyst playing several critical roles that directly facilitate fusion of the vesicles with the cell membrane to drive cargo delivery,” Munson said.

Seung-Hak Lee, medical student, School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul, South Korea

Robust control of exocytosis is critical for all cells to grow, divide and communicate properly. Dysfunction of exocyst regulation has been linked to many physiological problems in different organisms.

“It’s really an exciting development in our field, as the exocyst complex had not previously been shown to directly control vesicle fusion,” Munson said. “The complex recognizes the right vessel, the right place on the cell surface and the right time for the cargo to be delivered. It does that by talking to the membrane fusion protein.”

In 2023, Munson received a National Institutes of Health award for $3.3 million over five years to support this research.

Munson was recently named a 2024 recipient of a Zenith Award from the Association for Women in Science. The award honors senior career professionals with a lifetime of innovative achievements in STEM and a commitment to workplace diversity.

This article is republished from the UMass Chan Medical School News. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Patrick Sargent
Patrick Sargent

Patrick Sargent joined the UMass Chan Medical School Communications team in 2022 as a communications writer, covering government and community relations stories, campus events and more for UMass Chan's online news and print publications. Before coming to UMass Chan, Pat was a journalist in the Worcester area for nearly a decade.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.